광동제약: management transactions · South Korea · DART (FSS)

Browse the full insider trade history of 광동제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Consumer Defensive sector, 광동제약 has logged 4 reports. Market capitalisation: €270.5bn. The latest transaction was disclosed on 14 April 2026 — Other. Among the most active insiders: 최성원. The full history is accessible without an account.